Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study

Rikke Riber-Hansen; Nina Hastrup; Ole Clemmensen; Nille Behrendt; Siri Klausen; Mette Ramsing; Eva Spaun; Stephen Jacques Hamilton-Dutoit; Torben Steiniche

doi:10.1016/j.ejca.2011.08.019

Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study

Rikke Riber-Hansen, Nina Hastrup, Ole Clemmensen, Nille Behrendt, Siri Klausen, Mette Ramsing, Eva Spaun, Stephen Jacques Hamilton-Dutoit, Torben Steiniche

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

17 Citationer (Scopus)

Abstract

Metastasis size in melanoma sentinel lymph nodes (SLNs) is an emerging prognostic factor. Two European melanoma treatment trials include SLN metastasis diameters as inclusion criteria. Whilst diameter estimates are sensitive to the number of sections examined, the level of this bias is largely unknown. We performed a prospective multicentre study to compare the European Organisation for Research and Treatment of Cancer (EORTC) recommended protocol with a protocol of complete step-sectioning.

Originalsprog	Engelsk
Tidsskrift	European Journal of Cancer
Vol/bind	48
Udgave nummer	3
Sider (fra-til)	347-52
Antal sider	6
ISSN	0959-8049
DOI	https://doi.org/10.1016/j.ejca.2011.08.019
Status	Udgivet - 2012

Adgang til dokumentet

10.1016/j.ejca.2011.08.019

Citationsformater

Riber-Hansen, R., Hastrup, N., Clemmensen, O., Behrendt, N., Klausen, S., Ramsing, M., Spaun, E., Hamilton-Dutoit, S. J., & Steiniche, T. (2012). Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study. European Journal of Cancer, 48(3), 347-52. https://doi.org/10.1016/j.ejca.2011.08.019

Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study. / Riber-Hansen, Rikke; Hastrup, Nina; Clemmensen, Ole et al.
I: European Journal of Cancer, Bind 48, Nr. 3, 2012, s. 347-52.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Riber-Hansen, R, Hastrup, N, Clemmensen, O, Behrendt, N, Klausen, S, Ramsing, M, Spaun, E, Hamilton-Dutoit, SJ & Steiniche, T 2012, 'Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study', European Journal of Cancer, bind 48, nr. 3, s. 347-52. https://doi.org/10.1016/j.ejca.2011.08.019

@article{6ab0a88d470444d7809a66449d007ff5,

title = "Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study",

abstract = "Metastasis size in melanoma sentinel lymph nodes (SLNs) is an emerging prognostic factor. Two European melanoma treatment trials include SLN metastasis diameters as inclusion criteria. Whilst diameter estimates are sensitive to the number of sections examined, the level of this bias is largely unknown. We performed a prospective multicentre study to compare the European Organisation for Research and Treatment of Cancer (EORTC) recommended protocol with a protocol of complete step-sectioning.",

author = "Rikke Riber-Hansen and Nina Hastrup and Ole Clemmensen and Nille Behrendt and Siri Klausen and Mette Ramsing and Eva Spaun and Hamilton-Dutoit, {Stephen Jacques} and Torben Steiniche",

year = "2012",

doi = "10.1016/j.ejca.2011.08.019",

language = "English",

volume = "48",

pages = "347--52",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

number = "3",

}

TY - JOUR

T1 - Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning

T2 - a national multicentre study

AU - Riber-Hansen, Rikke

AU - Hastrup, Nina

AU - Clemmensen, Ole

AU - Behrendt, Nille

AU - Klausen, Siri

AU - Ramsing, Mette

AU - Spaun, Eva

AU - Hamilton-Dutoit, Stephen Jacques

AU - Steiniche, Torben

PY - 2012

Y1 - 2012

N2 - Metastasis size in melanoma sentinel lymph nodes (SLNs) is an emerging prognostic factor. Two European melanoma treatment trials include SLN metastasis diameters as inclusion criteria. Whilst diameter estimates are sensitive to the number of sections examined, the level of this bias is largely unknown. We performed a prospective multicentre study to compare the European Organisation for Research and Treatment of Cancer (EORTC) recommended protocol with a protocol of complete step-sectioning.

AB - Metastasis size in melanoma sentinel lymph nodes (SLNs) is an emerging prognostic factor. Two European melanoma treatment trials include SLN metastasis diameters as inclusion criteria. Whilst diameter estimates are sensitive to the number of sections examined, the level of this bias is largely unknown. We performed a prospective multicentre study to compare the European Organisation for Research and Treatment of Cancer (EORTC) recommended protocol with a protocol of complete step-sectioning.

U2 - 10.1016/j.ejca.2011.08.019

DO - 10.1016/j.ejca.2011.08.019

M3 - Journal article

C2 - 22023888

SN - 0959-8049

VL - 48

SP - 347

EP - 352

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 3

ER -